Key result
Underserved US minorities receive TAVR and SAVR for AS at disproportionately low rates.
Why the study?
Underserved minorities undergo transcatheter and surgical aortic valve replacement for aortic stenosis at disproportionately low rates due to multiple factors including disease prevalence and healthcare access.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Underserved populations have all sorts of characteristics. We tend to focus on race, sex, and ethnicity, but the elderly can be underserved and rural Americans who live from far distances from TAVR centers and centers of expertise can have access issues.”
“It is such a standard approach to target narrowing gaps in care that is should be deployed without hesitancy.”
Narrative review reveals substantial treatment gaps in underserved populations with aortic stenosis, suggesting multi-level structural strategies to achieve equitable care.
Underserved minorities make up a disproportionately small subset of patients in the United States undergoing transcatheter and surgical aortic valve replacement for aortic stenosis. The reasons for these treatment gaps include differences in disease prevalence and patient, health care system, and disease-related factors. This has major implications not only for minority patients, but also for other groups who face similar challenges in accessing state-of-the-art care for structural heart disease. The authors propose the following key strategies to address these treatment disparities: 1) implementation of measure-based quality improvement programs; 2) effective culturally competent communication and team-based care; 3) improving patient health care access, education, and effective diagnosis; and 4) changing the research paradigm that creates an innovation pipeline for patients. Only a concerted effort from all stakeholders will achieve equitable and broad application of this and other novel structural heart disease treatment modalities in the future.
No takes yet. Share an insight, caveat, or question.
Batchelor et al. (2019) conducted a review in Aortic Valve Stenosis. Transcatheter and surgical aortic valve replacement was evaluated. Underserved minorities in the United States undergo transcatheter and surgical aortic valve replacement for aortic stenosis at disproportionately low rates.
Synapse has enriched 10 related papers. Consider them for comparative context: